🦴 "How many pores can you see?" 🔍 This is the question we ask every time we bioprint a Bon3OID™. With 36 visible pores, our Bon3OIDs provide remarkable insights—for example, into how a patient’s monocytes from peripheral blood mononuclear cells form osteoclasts. In bone disease patients, this information is crucial—it can help save quality of life, time, and costs. ⏳💡 🔬 Stay tuned for more insights! #OrganotypicBoneModels #BoneOrganoids #BoneDiseases #FunctionalBoneBiomarkers
CompagOs
Medizinische und diagnostische Labore
Pioneering Solutions to Understand, Diagnose, and Treat Bone Conditions
Info
CompagOs is bringing better bone health to all by empowering researchers to transform discoveries into clinical applications, while enabling physicians to match patients with the right treatments and support faster recovery. At the core of our mission are our biologically relevant and reproducible Bon3OID™ in vitro bone models, developed using state-of-the-art 3D bioprinting. Leveraging this technology, we are currently focused on developing a blood-based assay to detect bone metastases earlier than existing imaging methods, representing a key step toward advancing bone health. Additionally, we provide comprehensive services to academic researchers and the life sciences industry, utilizing these models for basic research, drug efficacy, and toxicity testing, with a focus on bone biology, rare bone diseases, inflammatory bone disorders, and bone oncology.
- Website
-
https://compagos.ch
Externer Link zu CompagOs
- Branche
- Medizinische und diagnostische Labore
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Zürich
- Art
- Privatunternehmen
- Spezialgebiete
- organotypic bone models, 3D bioprinting, bone biology, bone oncology, rare bone diseases, inflammatory bone diseases, personalized medicine und bone regeneration
Orte
-
Primär
Zürich, CH
Beschäftigte von CompagOs
-
Anil Sethi
I teach
-
Chris Steffi
Postdoctoral Researcher | Sciencepreneur | Co-Founder & Board Member at CompagOs | Advancing Bone Organoid Research and Personalised Medicine
-
Robert Baumann
Chief Operating Officer at CompagOs
-
Barna Gal, MD
Co-founder at CompagOs | Transforming Drug Development, Personalized Treatments and Regenerative Medicine with Bon3OID™ in vitro Models
Updates
-
📺 Don’t forget to tune in! 📺 In less than 2 hours, watch Gian Nutal S. share key insights about our Bon3OID™ models and their impact in the bone space. 🦴💡
🚀 I’m excited to be selected for the De Vigier Top 50! Ever wondered what I’ve been working on lately? This is your chance to find out! Join me on Tuesday, February 25th, for the live-streamed pitches at https://lnkd.in/du-XabZm. I’ll be pitching in the #LifeSciencesBiotechPharma category from 09:15 to 10:15 AM, with my slot at 09:50 AM. #SwissStartups #devigier #StartupCompetition
-
-
📅 Mark your calendars for February 25! We’re excited that Gian Nutal S. will be pitching our technology alongside Switzerland’s most promising startups, showcasing groundbreaking innovations. 💻 Tune in to the livestream at www.devigier.ch and get a heavy dose of bone inspiration! #BoneHealth #devigier #Innovation #Entrepreneurship
🤩 The wait is over! The W.A. de Vigier Foundation proudly presents the Top 50 startups shortlisted in this year’s competition. 🎤 Watch them pitch live on Selection Day, February 25 – a showcase of Switzerland’s most promising innovations across a wide range of industries! 💻 Tune in to the livestream at www.devigier.ch and get a heavy dose of inspiration! #StartupCompetition #SwissStartups #devigier
-
📅 In just 2 days, we're heading to Pratteln for the 4th Next-Gen Organ-on-Chips & Organoids Workshop! 👋 Meet our Co-founder, Gian Nutal S., at our booth or around the event. ✨ Don't miss his presentation on Thursday, 13.02, at 14:55 during the scientific program, where he will discuss our in vitro bone model platform! 📩 Feel free to reach out directly to schedule a meeting with him in advance. 👉 For more details, visit: https://lnkd.in/en7Tf-FH See you at the event, and thanks to CSEM for inviting us! 🤝 #BoneHealth #OrganotypicBoneModels #BoneOrganoids
-
Our co-founders, Gian Nutal S. and Chris Steffi, had an amazing time connecting with the orthopedic community at this year's Annual Meeting of the Orthopaedic Research Society! ✅ Engaging with experts & students at our booth ✅ Chris presenting our science through her scientific poster and talk at the Industry Innovation Session ✅ Gian pitching CompagOs at the Business Innovation Competition Excited to drive orthopedic innovation forward! #ORS2025 #Orthopedics #Innovation #Biotech #CompagOs
-
-
This week, we had the pleasure of welcoming our collaborators from CSEM and Université de Fribourg/Universität Freiburg as we officially kicked off our joint project! 🚀 Together, we are working on a scalable solution to detect early signs of metastatic bone disease 🦴 from a blood sample🩸 using our cutting-edge Bon3OID™ in vitro model technology. Our initial focus is on lung cancer patients, but the potential goes far beyond! This technology could be a game-changer for: 🔹 Other cancers like breast & prostate 🔹 Bone diseases such as osteoporosis & rheumatoid arthritis We are excited about this promising partnership and look forward to sharing our progress with you! Stay tuned! 🔥🔍 Gian Nutal S. Robert Baumann Alessandra Curioni Fontecedro Angelica Rigutto, PhD Gilles Weder Robert Wimbish Christian Beyer Stéphanie Boder-Pasche #Innovation #BoneHealth #3DInVitroBoneModels #CancerDiagnostics #3DBioprinting #LifeSciences #Healthcare
-
-
🎉 Congratulations, Julia Schüpfer, on this fantastic achievement! 👏✨ We’re incredibly grateful to have you on our team and appreciate your dedication to improving our technology every day. 🚀💡 Thank you for your hard work and passion!
Herzlichen Glückwunsch, Julia Schüpfer! 🎉 Julia wurde für ihre herausragenden akademischen Leistungen mit dem Hirschmann Stipendium ausgezeichnet. 🏆 Ihre Bachelorarbeit führte sie in der Fachgruppe Mikrobiologie und Molekularbiologie durch. Dabei entwickelte sie ein in vitro Modell zur Untersuchung neuer Wirkstoffe gegen Krebs. Ein besonderer Fokus lag auf der rekombinanten Herstellung der katalytischen Domäne von MMP-9 – einem Enzym mit enger Verbindung zur Krebsforschung. Aktuell studiert Julia im Master Life Sciences mit der Vertiefung Pharmaceutical Biotechnology. Ihre Masterarbeit schreibt sie extern beim Startup CompagOs, wo sie an der Verbesserung und Standardisierung des 3D-Drucks von Knochenorganoiden arbeitet. Diese Organoide sollen künftig in einem Assay zur Früherkennung von rapidem Knochenverlust eingesetzt werden. Während ihrer Masterarbeit wird sie von Prof. Dr. Rainer Riedl im Competence Center for Drug Discovery in der Medizinalchemie-Gruppe betreut. Wir gratulieren herzlich zu dieser grossartigen Auszeichnung und wünschen weiterhin viel Erfolg! 📚 #zhaw #icbt #stipendium #lifesciences #pharmaceuticalbiotechnology #cancerresearch #3dprinting
-
-
🌵 Phoenix, Arizona – We’re Coming Your Way! 🌞 In less than 10 days, our team is heading to Phoenix, Arizona to join fellow colleagues at the Annual Meeting of the Orthopaedic Research Society! 🦴🔬 🚀 Meet Our Co-Founders, Chris Steffi & Gian Nutal S.! They’re excited to connect and discuss bone health and how we can support your bone research endeavors. 📢 Join Us at Our Poster Presentation! We’ll be showcasing our Bon3OID™-OC model, a cutting-edge bone remodeling in vitro model incorporating osteoblasts, osteocytes, and osteoclasts. Don’t miss the chance to explore its potential! 🗓 Where to Find Us? 🎤 Chris Presents: The Innovation Behind our Bon3OID™ Models 📅 Saturday, February 8 ⏰ 11:45 AM – 1:15 PM 📍 North 224 🚀 Gian Pitches at the Business Innovation Competition 📅 Monday, February 10 ⏰ 1:30 PM – 3:00 PM 📍 North 224 📩 Want to schedule a meeting in advance? Feel free to reach out to Chris or Gian—they’d be happy to connect! We can’t wait to see you in Phoenix! 🔥🌵 #OrthopedicResearch #BoneHealth #ORS2025 #PhoenixArizona #InnovationInResearch #BoneHealth #OrganotypicBoneModels #BoneRegeneration #BoneMetastases #RheumatoidArthritis #Osteoporosis #Osteomyelitis #OsteogenesisImperfecta #Osteosarcoma
-
✨ Just a few days to go until the #DeepTechInvestorSummit – and we can't wait to be part of it! 🚀 🦴 Visit us at Booth #52 to discover how we’re pioneering the future of bone health. 🤝 Connect with Gian Nutal S. on the b2match platform or LinkedIn for a 1-on-1 meeting. 📍 Event Details: https://lnkd.in/epPb-gsA 📅 Date: January 27–28, 2025 📌 Location: ETH Main Building (HG), Rämistrasse 101, 8006 Zürich, Switzerland Looking forward to meeting you there! 🌟🙌
I am looking forward to attending the #DeepTechInvestorSummit and connect with innovators and investors passionate about transforming healthcare! 🌟 At CompagOs, we are pioneering solutions in early cancer diagnostics, focusing on bone health—a critical yet often overlooked aspect of cancer care. Our Bon3OID™-Dx blood-based diagnostic solution is set to redefine how skeletal complications in cancer patients are detected and managed, enabling earlier intervention and better outcomes. If you’re interested in supporting deeptech innovation and joining us in tackling this health challenge, let’s connect! Together, we can shape the future of cancer care and bone health. 💡 #ETHSpinOff #PreSeed #BetterBoneHealth #DeepTech
-
-
🌟 We can’t wait to meet you! 🌟 Several incredible events are just around the corner! 🚀🎉 These gatherings provide fantastic opportunities to network, build connections, and explore exciting new partnerships. Where can you find us? 📅 Deep Tech Investor Summit 🗓️ Date: 27 – 28.01 📍 Location: Zürich, Switzerland 🔗 Link: https://lnkd.in/epPb-gsA 📅 2025 Annual Meeting of The Orthopaedic Research Society 🗓️ Date: 07 – 11.02 📍 Location: Phoenix, USA 🔗 Link: https://lnkd.in/gmcJvEd7 📅 4th Next-gen Organ-on-chips & Organoids 🗓️ Date: 13 – 14.02 📍 Location: Pratteln, Switzerland 🔗 Link: https://lnkd.in/en7Tf-FH We’re excited to connect with fellow professionals, investors, customers, and bone health enthusiasts to explore new opportunities for partnership. If you’re attending any of these events, we’d love to see you—stop by our booth or schedule a meeting in advance! See you there! 💬🤝 #Networking #Innovation #BoneHealth #OrganotypicBoneModels
-